MCF Advisors LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 1 filers reported holding TRANSMEDICS GROUP INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MCF Advisors LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$32,084
-30.4%
586
+6.7%
0.00%
-25.0%
Q2 2023$46,106
-0.4%
549
-10.1%
0.00%0.0%
Q1 2023$46,272
-5.7%
611
-23.1%
0.00%
-20.0%
Q4 2022$49,067
+14.1%
795
-23.7%
0.01%0.0%
Q3 2022$43,0001,0420.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2023
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders